| Balance Sheets | 2025-09-30 | 2025-06-30 | ||
|---|---|---|---|---|
| Cash and cash equivalents | 4,569,038 | 3,218,067 | ||
| Accounts receivable, net | 572,199 | 254,584 | ||
| Inventory | 5,783,974 | 5,232,738 | ||
| Prepaid and other current assets | 1,321,689 | 1,045,591 | ||
| Total current assets | 12,246,900 | 9,750,980 | ||
| Leasehold improvements | 1,238,886 | 1,238,886 | ||
| Office equipment | 78,155 | 68,530 | ||
| Furniture and fixtures | 417,876 | 417,876 | ||
| Machinery and equipment | 3,283,672 | 3,211,109 | ||
| Construction in progress | 687,462 | 548,426 | ||
| Property and equipment, gross | 5,706,051 | 5,484,827 | ||
| Less accumulated depreciation | 3,956,987 | 3,884,964 | ||
| Net property and equipment | 1,749,064 | 1,599,863 | ||
| Lease right-of-use assets, net | 1,419,345 | 1,544,724 | ||
| Intangible assets, net of accumulated amortization | 130,041 | 55,638 | ||
| Other long-term assets | 744,803 | 829,204 | ||
| Total long-term assets | 2,294,189 | 2,429,566 | ||
| Total assets | 16,290,153 | 13,780,409 | ||
| Convertible notes payable, net (including related parties) | - | 6,080,813 | ||
| Accounts payable | 2,173,883 | 3,263,584 | ||
| Accrued expenses | 1,028,461 | 1,052,752 | ||
| Note payable | 276,489 | - | ||
| Convertible notes payable, net (including related parties) | 6,507,354 | - | ||
| Clinical holdback current portion | 60,543 | 63,990 | ||
| Operating lease liabilities current portion | 494,954 | 502,468 | ||
| Total current liabilities | 10,541,684 | 10,963,607 | ||
| Clinical holdback long-term portion | 43,955 | 40,348 | ||
| Lease liabilities long-term portion | 1,148,263 | 1,269,019 | ||
| Total long-term liabilities | 1,192,218 | 1,309,367 | ||
| Total liabilities | 11,733,902 | 12,272,974 | ||
| Common stock, 0.001 par, 200,000,000 authorized,47,419,596 shares issued and 47,302,373 outstanding as of september 30, 2025 and 23,473,149 shares issued and 23,355,926 outstanding as of december 31, 2024 | 47,420 | 32,693 | ||
| Treasury stock, 117,223 common shares | 60,000 | 60,000 | ||
| Warrants | 6,727,334 | 1,821,744 | ||
| Additional paid-in-capital | 139,717,336 | 137,394,016 | ||
| Accumulated deficit | -141,875,839 | -137,681,018 | ||
| Total stockholders equity | 4,556,251 | 1,507,435 | ||
| Total liabilities and stockholders' equity | 16,290,153 | 13,780,409 | ||
FEMASYS INC (FEMY)
FEMASYS INC (FEMY)